Researchers have found that the basic ingredient of turmeric, when administered in a nanoparticle formulation has several favourable properties in the treatment of tuberculosis in mice.
The results were published in the journal Frontiers in Immunology Results of the Research. During the research, regular curcumin was able to drastically reduce liver toxicity induced by TB drug isoniazid
- Also, the treatment of TB with isoniazid along with 200 nanometre curcumin nanoparticles led to “dramatically reduced” risk of disease reactivation and reinfection.
- Because of the increased bioavailability of curcumin, the duration of treatment to achieve complete eradication of the bacteria is reduced significantly Other positive effects of using ‘Curcumin’Quite often, patients stop taking anti-TB drugs for a few days due to liver toxicity
Since the addition of curcumin reduces liver toxicity there can be better treatment and lesser risk of drug resistance emerging.